|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/20 | (2006.01) |
| A61K 38/2013 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 38/2086 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3359182 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16791713.7 |
| Europos patento paraiškos padavimo data | 2016-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/056088 |
| Data | 2016-10-07 |
| (87) | Numeris | WO 2017/062832 |
| Data | 2017-04-13 |
| (30) | Numeris | Data | Šalis |
| 201562239207 P | 2015-10-08 | US |
| (72) |
CHARYCH, Deborah , US
KIRK, Peter , GB
|
| (73) |
Nektar Therapeutics ,
455 Mission Bay Boulevard South
Suite 100, San Francisco, CA 94158,
US
|
| (54) | COMBINATION OF AN IL-2RBETA-SELECTIVE AGONIST AND A LONG-ACTING IL-15 AGONIST |
| COMBINATION OF AN IL-2RBETA-SELECTIVE AGONIST AND A LONG-ACTING IL-15 AGONIST |